Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Structure Therapeutics Inc. Director's Dealing 2023

Oct 12, 2023

31940_dirs_2023-10-12_01a3e1df-37be-4a07-b440-08bdbb968393.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2023-10-02

Reporting Person: FMR LLC (10% Owner, See Remark 1)

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 61527 Indirect
Ordinary Shares 723837 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
American Depository Shares $ Ordinary Shares (4769400) Indirect
American Depository Shares $ Ordinary Shares (123) Indirect

Footnotes

F1: Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted to three Ordinary Shares at any time at the election of the holder upon notice.